Table 1.
Liver biopsy data on patients who underwent EUS-LB from January 2018 to August 2019 (n = 30)
| Case # | Age | Needle gauge | Core length (mm) | n portal tracts | Fibrosis stage | Histological diagnosis |
|---|---|---|---|---|---|---|
| 1 | 63 | 19 | 30 | 5 | 4 | CHC |
| 2 | 56 | 19 | 43 | 1 | 3 | NASH |
| 3 | 39 | 22 | 80 | 6 | 1 | NASH |
| 4 | 37 | 19 | 25 | 9 | 1 | FLD |
| 5 | 33 | 19 | 68 | 9 | 0 | GH |
| 6 | 64 | 19 | 15 | 6 | 0 | FLD |
| 7 | 46 | 19 | 37 | 5 | 0 | FLD |
| 8 | 53 | 19 | 16 | 8 | 0 | FLD |
| 9 | 51 | 19 | 27 | 5 | 2 | PBC |
| 10 | 53 | 19 | 20 | 6 | 2 | PFIC |
| 11 | 48 | 19 | 19 | 5 | 1 | FLD |
| 12 | 54 | 22 | 33 | 5 | 0 | NASH |
| 13 | 52 | 19 | 25 | 5 | 1 | NASH |
| 14 | 46 | 19 | 26 | 6 | 0 | CHC |
| 15 | 39 | 22 | 45 | 8 | 2 | NASH |
| 16 | 54 | 19 | 23 | 4 | 2 | CHC |
| 17 | 32 | 19 | 25 | 9 | 1 | NASH |
| 18 | 72 | 19 | 24 | 4 | 1 | NASH |
| 19 | 62 | 19 | 25 | 1 | 0 | EH |
| 20 | 65 | 19 | 25 | 5 | 2 | NASH |
| 21 | 55 | 19 | 20 | 6 | 3 | NASH |
| 22 | 48 | 19 | 15 | 5 | 3 | NASH |
| 23 | 63 | 19 | 25 | 4 | 4 | NASH |
| 24 | 55 | 19 | 21 | 8 | 2 | CHC |
| 25 | 48 | 19 | 28 | 6 | 1 | NASH |
| 26 | 70 | 19 | 55 | 42 | 4 | NASH |
| 27 | 59 | 19 | 21 | 5 | 2 | NASH |
| 28 | 54 | 19 | 24 | 10 | 4 | NASH |
| 29 | 64 | 19 | 20 | 6 | 2 | Hemochromatosis |
| 30 | 33 | 19 | 22 | 5 | 3 | NASH |
CHC chronic hepatitis C, GH granulomatous hepatitis, EH eosinophilic hepatitis, FLD fatty liver disease, NASH non-alcoholic steatohepatitis, PBC primary biliary cholangitis, PFIC progressive familial intrahepatic cholestasis